JPMorgan Chase & Co’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $106M | Buy |
4,353,952
+920,430
| +27% | +$22.4M | 0.01% | 844 |
|
2025
Q1 | $71.3M | Buy |
3,433,522
+641,951
| +23% | +$13.3M | 0.01% | 999 |
|
2024
Q4 | $65.7M | Sell |
2,791,571
-163,708
| -6% | -$3.85M | ﹤0.01% | 1034 |
|
2024
Q3 | $75.7M | Buy |
2,955,279
+699,901
| +31% | +$17.9M | 0.01% | 993 |
|
2024
Q2 | $53M | Buy |
2,255,378
+1,124,827
| +99% | +$26.4M | ﹤0.01% | 1111 |
|
2024
Q1 | $32.5M | Buy |
1,130,551
+797,006
| +239% | +$22.9M | ﹤0.01% | 1404 |
|
2023
Q4 | $10.9M | Buy |
333,545
+104,276
| +45% | +$3.42M | ﹤0.01% | 2039 |
|
2023
Q3 | $6.39M | Buy |
229,269
+35,724
| +18% | +$995K | ﹤0.01% | 2278 |
|
2023
Q2 | $6.6M | Buy |
193,545
+8,712
| +5% | +$297K | ﹤0.01% | 2323 |
|
2023
Q1 | $5.56M | Buy |
184,833
+168,398
| +1,025% | +$5.06M | ﹤0.01% | 2368 |
|
2022
Q4 | $464K | Sell |
16,435
-1,452
| -8% | -$41K | ﹤0.01% | 3800 |
|
2022
Q3 | $588K | Buy |
17,887
+2,633
| +17% | +$86.6K | ﹤0.01% | 3649 |
|
2022
Q2 | $480K | Sell |
15,254
-220,225
| -94% | -$6.93M | ﹤0.01% | 3907 |
|
2022
Q1 | $10.8M | Sell |
235,479
-219,773
| -48% | -$10.1M | ﹤0.01% | 1971 |
|
2021
Q4 | $27.9M | Buy |
455,252
+75,140
| +20% | +$4.6M | ﹤0.01% | 1354 |
|
2021
Q3 | $28.4M | Buy |
380,112
+41,365
| +12% | +$3.09M | ﹤0.01% | 1338 |
|
2021
Q2 | $31.3M | Buy |
338,747
+20,895
| +7% | +$1.93M | ﹤0.01% | 1330 |
|
2021
Q1 | $28.2M | Buy |
317,852
+224,948
| +242% | +$20M | ﹤0.01% | 1349 |
|
2020
Q4 | $8.66M | Buy |
92,904
+84,565
| +1,014% | +$7.89M | ﹤0.01% | 2013 |
|
2020
Q3 | $535K | Sell |
8,339
-5,269
| -39% | -$338K | ﹤0.01% | 3356 |
|
2020
Q2 | $709K | Buy |
13,608
+2,947
| +28% | +$154K | ﹤0.01% | 3171 |
|
2020
Q1 | $334K | Buy |
10,661
+2,438
| +30% | +$76.4K | ﹤0.01% | 3491 |
|
2019
Q4 | $276K | Buy |
+8,223
| New | +$276K | ﹤0.01% | 3707 |
|